antihemophilic

antihemophilic

 [an″te-, an″ti-he″mo-fil´ik]
1. effective against the bleeding tendency in hemophilia.
2. an agent that has this effect.

antihemophilic

/an·ti·he·mo·phil·ic/ (-he″mo-fil´ik) counteracting hemophilia, or an agent that so acts.

an·ti·he·mo·phil·ic

(an'tē-hē-mō-fil'ik)
Correcting or counteracting the hemorrhagic tendency in hemophilia.
Synonym(s): antihaemophilic.
[anti- + hemophilic]

antihemophilic

1. effective against the bleeding tendency in hemophilia.
2. an agent that counteracts the bleeding tendency in hemophilia.

antihemophilic factor (AHF) A
one of the clotting factors, deficiency of which causes von willebrand's disease and hemophilia A. Called also factor VIII and antihemophilic globulin.
antihemophilic factor B
clotting factor IX.
antihemophilic factor C
clotting factor XI.
References in periodicals archive ?
Adynovi is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding, Shire says in a statement.
Antihemophilic Factor Human Method M Monoclonal Purified Factor Viii 250 Iu
Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure.
Octapharma USA has received Food and Drug Administration approval for Nuwiq, Antihemophilic Factor (Recombinant), an intravenous therapy for adults and children living with hemophilia A.
All our patients who developed inhibitor had severe hemophilia and were treated with antihemophilic factor previously.
Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.
Judith Pool, an American physiologist at Stanford University, discovers that slowly thawed frozen plasma yields deposits high in Factor VIII (or Antihemophilic Factor).
Production of high-potency concentrates of antihemophilic globulin in a closed-bag system.
The new treatment, called Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin Free, is a genetically engineered version of factor VIII, a protein essential for the clotting of blood.
Thromboembolic events have been reported in vWF patients treated with Antihemophilic Factor/von Willebrand Factor Complex replacement therapy.
Prior to her death from trauma, the previously healthy female donor received 53 units of blood components and 1 pool of antihemophilic factor, the researchers noted.